Published in Women's Health Weekly, March 18th, 2004
As the number of breast cancer patients rises and hospitals struggle to meet the growing cost of healthcare provision, the new research, by a U.K. physicist and two biostatisticians in France, could help divert funds into frontline treatment such as chemotherapy drugs and better imaging technology.
Doctors currently see patients for follow-up examinations for up to 10 years to check for tumor recurrence. Until now, the length of this follow-up period has been guess-work by...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.